- Home
- TWLO vs PODD Comparison
TWLO vs PODD Comparison
Compare TWLO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWLO
- PODD
- Stock Information
- Founded
- TWLO 2008
- PODD 2000
- Country
- TWLO United States
- PODD United States
- Employees
- TWLO N/A
- PODD N/A
- Industry
- TWLO Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- TWLO Technology
- PODD Health Care
- Exchange
- TWLO Nasdaq
- PODD Nasdaq
- Market Cap
- TWLO 20.0B
- PODD 21.5B
- IPO Year
- TWLO 2016
- PODD 2007
- Fundamental
- Price
- TWLO $105.67
- PODD $321.27
- Analyst Decision
- TWLO Buy
- PODD Strong Buy
- Analyst Count
- TWLO 26
- PODD 19
- Target Price
- TWLO $130.12
- PODD $324.68
- AVG Volume (30 Days)
- TWLO 4.4M
- PODD 708.9K
- Earning Date
- TWLO 08-07-2025
- PODD 08-07-2025
- Dividend Yield
- TWLO N/A
- PODD N/A
- EPS Growth
- TWLO N/A
- PODD N/A
- EPS
- TWLO 0.13
- PODD 3.32
- Revenue
- TWLO $4,729,372,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- TWLO $10.74
- PODD $24.54
- Revenue Next Year
- TWLO $7.80
- PODD $17.48
- P/E Ratio
- TWLO $800.90
- PODD $96.68
- Revenue Growth
- TWLO 11.56
- PODD 26.00
- 52 Week Low
- TWLO $56.85
- PODD $180.31
- 52 Week High
- TWLO $151.95
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- TWLO 41.05
- PODD 67.49
- Support Level
- TWLO $91.84
- PODD $302.41
- Resistance Level
- TWLO $103.85
- PODD $322.80
- Average True Range (ATR)
- TWLO 5.54
- PODD 9.29
- MACD
- TWLO -2.87
- PODD 3.87
- Stochastic Oscillator
- TWLO 33.99
- PODD 96.70
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.